Description:

E2108 Step 2 Disease Evaluation Form (RECIST 1.1) NCT01242800 Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8E091CE3-4B63-4A3C-E040-BB89AD4304A1

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8E091CE3-4B63-4A3C-E040-BB89AD4304A1

Keywords:
Versions (3) ▾
  1. 8/27/12
  2. 1/8/15
  3. 6/8/15
Uploaded on:

June 8, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

E2108 Step 2 Disease Evaluation Form (RECIST 1.1) NCT01242800

INSTRUCTIONS: Complete this form and submit original to the ECOG Coordinating Center within one week of registration. Keep a copy for your files.

ECOG clinical trial administrative data
Data amendment
On Treatment
On Treatment Report Period (Choose one)
Disease Assessment
Were disease assessment results obtained this report period? (cycle)
TARGET LESIONS - NON-NODAL
Site Code
Method of Evaluation
cm
TARGET LESIONS - NODAL
Nontarget Lesions
Follow-Up Status of Lesion (s)
Cytology Result (For Site Code 04 effusion/ascites ONLY)
New Lesions
Was the appearance of any new lesions documented
Overall Response Per Recist Criteria - Target, Nontarget And New Lesions
Best Overall Response to date (response status of all target, non-target, and new lesions)
Has the patient progressed or relapsed
Were circulating tumor cells (CTCs) assessed (during this reporting period)
Symptomatic Deterioration
Is there symptomatic deterioration of the patient's health status
Comments

Similar models